All News #Library
Rare Diseases
Bayer Ditches 1 AAV Gene Therapy From Pompe Disease Pair
04 Mar 2026 //
FIERCE BIOTECH
Genethon Licenses Askbio For Pompe Disease Gene Therapy
14 Jan 2026 //
BUSINESSWIRE
FDA Accepts AskBio IND for AB-1009 in Pompe Disease LOPD
08 Jan 2026 //
GLOBENEWSWIRE
AskBio Receives EC Orphan Drug Designation for AB-1003 LGMD Treatment
27 Feb 2023 //
CONTRACT PHARMA
AskBio Receives EC Orphan Drug Designation through BrainVectis for AB-1003
27 Feb 2023 //
PR NEWSWIRE

Market Place
Sourcing Support